TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines

British Journal of Dermatology

Volumn 151, Issue 4, 2004, Pages 823-830

  Bäumer, Wolfgang ^a   Seegers, U ^a   Braun, M ^a   Tschernig, T ^b   Kietzmann, M ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allergic contact dermatitis; Cilomilast; CTACK; Diflorasone diacetate; RANTES; TARC

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CHEMOKINE; CILOMILAST; CUTANEOUS T CELL ATTRACTING CHEMOKINE; DIFLORASONE DIACETATE; PHOSPHODIESTERASE IV INHIBITOR; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLUENE DIISOCYANATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; EAR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; T LYMPHOCYTE;

ANIMALS; BETAMETHASONE; BRONCHODILATOR AGENTS; CARBOXYLIC ACIDS; CHEMOKINES; CHEMOKINES, CC; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; NITRILES; RANTES; T-LYMPHOCYTE SUBSETS;

EID: 8344270135     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06220.x     Document Type: Article

References (28)

1. Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993; 150: 3442-7.
2. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-71.
3. Kaburagi Y, Shimada Y, Nagaoka T et al. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1, MIP-1β, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001; 293: 350-5.
4. Goebeler M, Trautmann A, Voss A et al. Differential and sequential expression of multiple chemokines during elicitation of allergic contact hypersensitivity. Am J Pathol 2001; 158: 431-10.
5. Campbell JJ, Haraldsen G, Pan J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999; 400: 776-80.
6. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11: 81-8.
7. Vestergaard C, Kirstejn N, Cesser B et al. IL-10 augments the IFN-γ and TNF-α induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J Dermatol Sci 2001; 26: 46-54.
8. + T cells. Eur J Immunol 1999; 29: 2684-94.
9. Kakinuma T, Nakamura K, Wakugawa M et al. IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10 kDa) /CXCL10 release by TNF-α and IFN-γ in HaCaT cell line. Cytokine 2002; 20: 1-6.
10. + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000; 115: 640-6.
11. Morales J, Homey B, Vicari AP et al. CTACK, a skin-associated chemokine that preferentially attracts skin homing memory T cells. Proc Natl Acad Sci USA 1999; 96: 14470-5.
12. Homey B, Alenius H, Müller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002; 8: 157-65.
13. Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous Th lymphocyte trafficking. Blood 2003; 101: 1677-83.
14. Ehinger AM, Gorr G, Hoppmann J et al. Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation. Eur J Pharmacol 2000; 392: 93-9.
15. Bäumer W, Gorr G, Hoppman J et al. Effects of the phosphodiesterase 4 inhibitors SB 207499 and AWD 12-281 on the inflammatory reaction in a model of allergic dermatitis. Eur J Pharmacol 2002; 446: 195-200.
16. Bäumer W, Gorr G, Hoppman J et al. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis. J Pharm Pharmacol 2003; 55: 1107-14.
17. Hujanen ES, Terranova VP. Migration of tumor cells to organ-derived chemoattractants. Cancer Res 1985; 45: 3517-21.
18. Sinikovic B, Larbig M, Hedrich H-J et al. The numbers of leukocyte subsets in lung sections differ between intercellular adhesion molecule-1-/-, lymphocyte function-associated antigen-1-/- mice and intercellular adhesion molecule-1-/- mice after aerosol exposure to Haemophilus influenzae type-b. Virchows Arch 2001; 438: 362-9.
19. Dearman RJ, Basketter DA, Kimber I. Characterisation of chemical allergens as a function of divergent cytokine secretion profiles induced in mice. Toxicol Appl Pharmacol 1996; 138: 308-16.
20. Kimber I, Dearman RJ. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 2002; 46: 1-5.
21. Scheerens H, Buckley TL, Muis TL et al. Long-term topical exposure to toluene diisocyanate in mice leads to antibody production and in vivo airway hyperresponsiveness three hours after intranasal challenge. Am J Respir Crit Care Med 1999; 159: 1074-80.
22. Potter DW, Wederbrand KS. Total IgE antibody production in Balb/c mice after dermal exposure to chemicals. Fundam Appl Toxicol 1995; 26: 127-35.
23. Dearman RJ, Kimber I. Differential stimulation of immune function by respiratory and contact chemical allergens. Immunology 1991; 72: 563-70.
24. Ban M, Hettich D. Relationship between IgE positive cell numbers and serum total IgE levels in mice treated with trimellitic anhydride and dinitrochlorobenzene. Toxicol Lett 2001; 118: 129-37.
25. Hayashi M, Higashi K, Kato H, Kaneko H. Assessment of preferential Th1 or Th2 induction by low-molecular-weight compounds using a reverse transcription-polymerase chain reaction method: comparison of two mouse strains, C57BL/6 and Balb/c. Toxicol Appl Pharmacol 2001; 177: 38-45.
26. Cumberbatch M, Dearman RJ, Griffiths CEM, Kimber I. Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS 2003; 111: 797-804.
27. Gad SC, Dunn BJ, Dobbs DW et al. Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicol Appl Pharmacol 1986; 84: 93-114.
28. Vestergaard C, Yoneyama H, Murai M et al. Overproduction of Th2 CC chemokines TARC and MDC in the skin of the NC/Nga mouse correlates with exacerbation of atopic dermatitis like skin lesions. J Clin Invest 1999; 104: 1097-105.